2013 Results

Anonymous

Guest
http://ir.supernus.com/releasedetail.cfm?ReleaseID=832321

Operating loss for 2013 for you Supernus was $62 million dollars. Oxtellar XR did $10 million in 2013 and Trokendi XR will probably be right in that range but wont be reported until 1st quarter. Sunovian has all the resources in the world and we will destroy you guys. Our drug is better too and physicians are ready for a product that really works in epilepsy.

You guys won't even break even this year and will run an operating loss again in 2014. It's time for investors to give up on this sinking ship. These investors are just padding the pockets of former Shire leadership who are rubbing each other's backs and pockets while the company is driven into the ground. Why all the expansions when your cash burn is so high...crazy!
 






i just stumbled on this forum because i'm looking for a way to not have to pay $300 per month for my daughter's epilepsy medication. Oxtellar XR has been prescribed to her, but we can't afford the payment. Does anyone have a line on where to get it internationally like from Canada or Mexico? We live in South Dakota. Thanks...and if my posting here is not cool, I'm sorry.
 






























Nobody said anything about seizure freedom, calm down cowboy. The best thing to do at this point is to provide this parent enough samples to hold them over until they have the issue resolved.
 






Nobody said anything about seizure freedom, calm down cowboy. The best thing to do at this point is to provide this parent enough samples to hold them over until they have the issue resolved.

My mistake...glad your daughter has found help with Oxtellar XR...is that better?

I am amazed at how depressing the people on cafepharma are...never met so many anonymous people that relish in trying to stir the pot!